Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana

Completed

Conditions studied: New York Medical Marijuana Program Qualifying Conditions

In brief

The primary purpose of this research is to identify genetic factors that may affect the efficacy and safety of medical marijuana, regardless of condition. The pharmacogenomics test detects DNA variants, which may affect the way drugs work and are metabolized in the body and/or detect potential side effects.

Key facts

Study ID

NCT04083261

Run by

Columbia Care Inc.

People needed

157

Starts

2019-07-11

Expected to finish

2020-03-30

Last updated by the study team

2020-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and Females age 18 and older
• Currently obtaining medical marijuana products from Columbia Care LLC
• Willing to participate and consent to a DNA analysis
• Purchased product from Columbia Care for three consecutive encounters spanning a 6-month period

You may not qualify if…

• Unwillingness to participate and consent to a DNA analysis
• Unwillingness to answer a survey/questionnaire on patient satisfaction as related to product efficacy

Where it is running

• Columbia Care New York Dispensary — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.